Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

AbbVie bolsters UK R&D presence, inks $1.38bn IBD deal with Nxera | PharmaVoice

Pharma Tech

AbbVie bolsters UK R&D presence, inks $1.38bn IBD deal with Nxera

Nov 4, 2026, 11:36 AM

Read Full Article → AbbVie bolsters UK R&D presence, inks $1.38bn IBD deal with Nxera

AbbVie bolsters UK R&D presence, inks $1.38bn IBD deal with Nxera

Translate article text

Choose a language and wait for the translated text.

AbbVie will use the Oxford site to advance treatments for immunological, neurological and oncological diseases.